巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Alterity Therapeutics Limited

    ATHE
    0.620
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Alterity Therapeutics Limited - 延遲價格・最後更新於 16/08 10:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    0.620
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    24.88
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.400 - 0.560
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Alterity Therapeutics Limited
    證券代碼
    ATHE.US
    所屬板塊
    Biotechnology
    公司業務
    Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).
    發行量
    40114576
    公司總部
    460 Bourke Street, Level 3
    公司網址
    https://www.alteritytherapeutics.com
    公司電郵
    info@pranabio.com
    公司電話
    +61 393494906

    Alterity Therapeutics(ATHE.US)盤前大漲近40%

    格隆匯·
    Alterity Therapeutics(ATHE.US)盤前大漲近40%

    Alterity Therapeutics(ATHE.US)盤前大漲近40%

    格隆匯·
    Alterity Therapeutics(ATHE.US)盤前大漲近40%

    關於

    Alterity Therapeutics Limited(ATHE.US)所屬的行業板塊為Biotechnology。
    Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434).
    詳細公司背景可參考: https://www.alteritytherapeutics.com